1-11 of 11
Hong Zheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)

Qinglei Gao, Jianqing Zhu, Weidong Zhao, Yi Huang, Ruifang An, Hong Zheng, Pengpeng Qu, Li Wang, Qi Zhou, Danbo Wang, Ge Lou, Jing Wang, Ke Wang, John Low, Beihua Kong, Abdul Malik Rozita, Lim Chun Sen, Rutie Yin, Xing Xie, Jihong Liu, Wei Sun, Jingya Su, Chunyi Zhang, Rongyu Zang, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2278–2285.
https://doi.org/10.1158/1078-0432.CCR-21-3023
Published: 01 June 2022
View article titled, Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)
Open the PDF for Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA) in another window
Includes: Supplementary data
Journal Articles

Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Jhanelle E. Gray, Andreas Saltos, Tawee Tanvetyanon, Eric B. Haura, Ben Creelan, Scott J. Antonia, Michael Shafique, Hong Zheng, Wenjie Dai, James J. Saller, Zhihua Chen, Nishan Tchekmedyian, Kristen Goas, Ram Thapa, Theresa A. Boyle, Dung-Tsa Chen, Amer A. Beg
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6623–6632.
https://doi.org/10.1158/1078-0432.CCR-19-1305
Published: 15 November 2019
View article titled, Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer
Open the PDF for Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Editor's Note: Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment

Jilong Yang, Antti Ylipää, Yan Sun, Hong Zheng, Kexin Chen, Matti Nykter, Jonathan Trent, Nancy Ratner, Dina C. Lev, Wei Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (10): 3195.
https://doi.org/10.1158/1078-0432.CCR-19-1144
Published: 15 May 2019
View article titled, Editor's Note: Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment
Open the PDF for Editor's Note: Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment in another window
Journal Articles

Abstract 14: Elucidation of genetic susceptibility genes using next-generation sequencing (NGS) approach in nasopharyngeal carcinoma

Wei Dai, Hong Zheng, Josephine M.Y. Ko, Arthur K.L. Cheung, Maria Li Lung
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): 14.
https://doi.org/10.1158/1557-3265.AACRAHNS17-14
Published: 30 November 2017
View article titled, Abstract 14: Elucidation of genetic susceptibility genes using next-generation sequencing (NGS) approach in nasopharyngeal carcinoma
Journal Articles

Abstract B34: Integrated Approaches to Treating Lung Adenocarcinoma Resistant to Targeted Therapy

Jin Jen, Aaron Mansfield, Patrick W. Eiken, Shawn Stoddard, Karlyn Pierson, Xiaonan Hou, Hong Zheng Ren, Julian Molina, Joanne Yi, Ping Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): B34.
https://doi.org/10.1158/1557-3265.PDX16-B34
Published: 15 August 2016
View article titled, Abstract B34: Integrated Approaches to Treating Lung Adenocarcinoma Resistant to Targeted Therapy
Journal Articles

HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma

Hong Zheng, Weipeng Zhao, Cihui Yan, Crystina C. Watson, Michael Massengill, Mengyu Xie, Chris Massengill, David R. Noyes, Gary V. Martinez, Roha Afzal, Zhihua Chen, Xiubao Ren, Scott J. Antonia, Eric B. Haura, Brian Ruffell, Amer A. Beg
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16): 4119–4132.
https://doi.org/10.1158/1078-0432.CCR-15-2584
Published: 14 August 2016
View article titled, HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Open the PDF for HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients

Yaxian Kong, Liuluan Zhu, Todd D. Schell, Jianhong Zhang, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Melissa R. George, Hui Zeng, Hong Zheng
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (12): 3057–3066.
https://doi.org/10.1158/1078-0432.CCR-15-2626
Published: 14 June 2016
View article titled, T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8<sup>+</sup> T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
Open the PDF for T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8<sup>+</sup> T-Cell Exhaustion and Poor Clinical Outcome in AML Patients in another window
Includes: Supplementary data
Journal Articles

Integrated MicroRNA Network Analyses Identify a Poor-Prognosis Subtype of Gastric Cancer Characterized by the miR-200 Family

Fengju Song, Da Yang, Ben Liu, Yan Guo, Hong Zheng, Lian Li, Tao Wang, Jinpu Yu, Yanrui Zhao, Ruifang Niu, Han Liang, Hans Winkler, Wei Zhang, Xishan Hao, Kexin Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (4): 878–889.
https://doi.org/10.1158/1078-0432.CCR-13-1844
Published: 16 February 2014
View article titled, Integrated MicroRNA Network Analyses Identify a Poor-Prognosis Subtype of Gastric Cancer Characterized by the miR-200 Family
Open the PDF for Integrated MicroRNA Network Analyses Identify a Poor-Prognosis Subtype of Gastric Cancer Characterized by the miR-200 Family in another window
Includes: Supplementary data
Journal Articles

Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment

Jilong Yang, Antti Ylipää, Yan Sun, Hong Zheng, Kexin Chen, Matti Nykter, Jonathan Trent, Nancy Ratner, Dina C. Lev, Wei Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7563–7573.
https://doi.org/10.1158/1078-0432.CCR-11-1707
Published: 18 December 2011
View article titled, Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment
Open the PDF for Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment in another window
Includes: Supplementary data
Journal Articles

An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset

Fengju Song, Hong Zheng, Ben Liu, Sheng Wei, Hongji Dai, Lina Zhang, George A. Calin, Xishan Hao, Qingyi Wei, Wei Zhang, Kexin Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6292–6300.
https://doi.org/10.1158/1078-0432.CCR-09-0826
Published: 30 September 2009
View article titled, An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the <em>SET8</em> Gene Is Associated with Early Age of Breast Cancer Onset
Open the PDF for An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the <em>SET8</em> Gene Is Associated with Early Age of Breast Cancer Onset in another window
Journal Articles

Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol

Lev M. Berstein, Ji-Ping Wang, Hong Zheng, Wei Yue, Mark Conaway, Richard J. Santen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1530–1534.
https://doi.org/10.1158/1078-0432.CCR-0433-03
Published: 20 February 2004
View article titled, Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol
Open the PDF for Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol in another window